Journal
JOURNAL OF INFECTION AND CHEMOTHERAPY
Volume 21, Issue 5-6, Pages 392-394Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jiac.2014.11.007
Keywords
Cryptococcus liquefaciens; Fungemia; Central venous catheter; Voriconazole; (1-3) beta-D-glucan
Categories
Ask authors/readers for more resources
We describe a case of central venous catheter-related fungemia caused by Cryptococcus liquefaciens, a non-neoformans and non-gattii Cryptococcus, in a non-HIV patient. A 71-year-old man with diffuse large B-cell lymphoma receiving antineoplastic chemotherapy was febrile approximately 30 weeks after central venous port insertion, and C. liquefaciens was isolated from all three performed blood cultures as well as a central venous catheter tip culture. In vitro antifungal susceptibility tests showed that this yeast isolate was susceptible to low concentrations of amphotericin B, fluconazole, itraconazole and voriconazole yet was resistant to 5-fluorocytosine (MIC: >64 mu g/ml), unlike Cryptococcus neoformans. Treatment of the patient with oral and intravenous voriconazole was effective and consistent with the susceptibility tests. Although non-neoformans and non-gattii Cryptococcus spp. are considered nonpathogenic environmental yeast, they may rarely be the causative agents of serious infections in humans, as in the present case. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available